Likewise, further analyses employing larger patient cohorts might help to further refine the diagnostic value of CD26/DPP4 expression in cutaneous T-cell lymphoma and to assess its suitability as a prognostic factor. The gene discussed is DPP4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.